ImmuCell (ICCC) · unaudited financial results for the quarter and year ended December 31, 2025
Date changed · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: February 25, 2026
The Company is planning to release its full, unaudited financial results for the quarter and year ended December 31, 2025 after the market closes on Wednesday, February 25, 2026 and is planning to host a conference call on Thursday, February 26, 2026 at 9:00 AM ET to discuss these results.
EX-99.1 · filed · SEC filing
After
Stated timing: March 4, 2026
On March 4, 2026 ImmuCell Corporation (the "Company") issued a press release announcing its unaudited financial results for the quarter and year ended December 31, 2025.
SEC original · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/ICCC-unaudited-financial-results-for-the-quarter-and-year-ended-2026-03-04, data as of Oct 14, 2026
https://www.orionbiotechai.com/changes/ICCC-unaudited-financial-results-for-the-quarter-and-year-ended-2026-03-04
ImmuCell (ICCC) pipeline and stated timing · Calendar · Companies A–Z